OXGN News Alert Oxigene Inc (OXGN) 1.59 12/25/2014 09:32:07

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Oxigene Inc (OXGN) 1.59 $OXGN

Biotech Stock Mailbag: Aethlon Medical, Oxigene, Sarepta
at The Street - Fri Dec 05, 5:00AM CST
Biotech columnist Adam Feuerstein answers readers' questions about health care.
OXGN: 1.59 (unch), BMRN: 88.18 (+0.89), RNA: 18.76 (+0.10), SRPT: 13.88 (+0.47)

OXiGENE Announces Preclinical Poster Presentation on OXi4503 at Upcoming American Society of Hematology Meeting
GlobeNewswire - Thu Nov 20, 7:00AM CST
OXiGENE, Inc. (Nasdaq:OXGN), a biopharmaceutical company developing novel cancer therapeutics, today announced that a poster presentation related to its clinical stage product candidate, OXi4503, will be presented at the American Society of Hematology (ASH) annual meeting taking place December 6-9, 2014 in San Francisco.
OXGN: 1.59 (unch)

OXiGENE Announces Issuance of European Patent for OXi4503 in Acute Myeloid Leukemia and other Myeloid Malignancies
GlobeNewswire - Mon Nov 17, 3:00PM CST
OXiGENE, Inc. (Nasdaq:OXGN), a biopharmaceutical company developing novel cancer therapeutics, today announced that the company has been granted a patent by the European Patent Office related to its current clinical product candidate, OXi4503. The patent (EP 2219451 B1) is drawn to the use of OXi4503 in treating non-solid myeloid neoplasm, including acute myeloid leukemia (AML).
OXGN: 1.59 (unch)

Hot Stock: OXiGENE, Shares Drop 5.3% (OXGN)
Comtex SmarTrend(R) - Mon Nov 17, 2:41PM CST
OXiGENE (NASDAQ:OXGN) is one of today's worst performing low-priced stocks, down 5.3% to $1.88 on 1.7x average daily volume. Thus far today, OXiGENE has traded 1.3 million shares, vs. average volume of 816,000 shares per day. The stock has underperformed the Dow (-5.3% to the Dow's 0.0%) and underperformed the S&P 500 (-5.3% to the S&P's -0.0%) during today's trading.
OXGN: 1.59 (unch)

Which Chemotherapy Should OXiGENE Test Their Zybrestat+Avastin Combo Against?
Clinically Sound Investor - at Seeking Alpha - Mon Nov 17, 10:42AM CST

OXGN: 1.59 (unch)

OXiGENE: Q3 Earnings And Avastin Approval, Bull Thesis Reiterated
Trevor Lowenthal - at Seeking Alpha - Fri Nov 14, 3:20PM CST

OXGN: 1.59 (unch)

Oxigene: Why I Think This Risky Biotech Is A Speculative Buy
Daniel Ward - at Seeking Alpha - Fri Nov 14, 8:15AM CST

OXGN: 1.59 (unch)

OXiGENE (OXGN) CEO Dr. Dave Chaplin on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Nov 12, 8:27PM CST

OXGN: 1.59 (unch)

OXiGENE (OXGN) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Wed Nov 12, 3:25PM CST

OXGN: 1.59 (unch)

OXiGENE beats by $0.06
Seeking Alpha - at Seeking Alpha - Wed Nov 12, 3:05PM CST

OXGN: 1.59 (unch)

OXiGENE Reports Third Quarter 2014 Financial Results
GlobeNewswire - Wed Nov 12, 3:02PM CST
- Positive Data from the Phase 2 GOG 186I Study in Ovarian Cancer Presented at Major Conference -
OXGN: 1.59 (unch)

Premarket Gainers / Losers
Seeking Alpha - at Seeking Alpha - Wed Nov 12, 8:18AM CST

ANV: 0.88 (+0.02), KEP: 19.78 (+0.05), RADA: 2.74 (+0.16), SEAS: 17.40 (-0.18), HPJ: 5.03 (+0.14), PLUG: 3.05 (-0.01), SUPN: 8.52 (+0.15), NBG: 1.95 (+0.06), GV: 2.25 (unch), OXGN: 1.59 (unch), NOAH: 20.44 (-1.00), FOSL: 109.78 (-0.20), AEO: 13.53 (+0.02), IBIO: 0.68 (-0.04), MTOR: 14.72 (+0.24), MLNX: 43.89 (+0.14), SUSQ: 13.43 (+0.01)

Oxigene Faces Challenges for Ovarian Cancer Drug Even With Encouraging Data
at The Street - Wed Nov 12, 4:12AM CST
An analysis of results from Oxigene's phase II study of fosbretabulin plus Avastin in recurrent ovarian cancer.
OXGN: 1.59 (unch), GSK: 42.85 (+0.11)

Update: OXiGENE Presents Zybrestat/Avastin Data, Bull Thesis Remains Intact
Trevor Lowenthal - at Seeking Alpha - Tue Nov 11, 4:56AM CST

OXGN: 1.59 (unch)

Stock to Watch: OXiGENE Down 6.9% (OXGN)
Comtex SmarTrend(R) - Mon Nov 10, 11:59AM CST
OXiGENE (NASDAQ:OXGN) is one of today's worst performing low-priced stocks, down 6.9% to $2.01 on 1.0x average daily volume. Thus far today, OXiGENE has traded 694,000 shares, vs. average volume of 663,000 shares per day. The stock has underperformed the Dow (-6.9% to the Dow's 0.2%) and underperformed the S&P 500 (-6.9% to the S&P's 0.3%) during today's trading.
OXGN: 1.59 (unch)

OxiGene presents Phase 2 data on fosbretabulin
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 11:31AM CST

OXGN: 1.59 (unch)

Head And Neck Cancer Squamous Cell Carcinoma Therapeutics Pipeline Report 2014 - 32 Companies & 65 DRug Profiles
M2 - Mon Nov 10, 10:26AM CST
Research and Markets (http://www.researchandmarkets.com/research/wml9ch/head_and_neck) has announced the addition of the "Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H2 2014" report to their offering. This report provides comprehensive information on the therapeutic development for Head And Neck Cancer Squamous Cell Carcinoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Head And Neck Cancer Squamous Cell Carcinoma and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Companies Involved in Therapeutics Development - Bristol-Myers Squibb Company - Boehringer Ingelheim GmbH - F. Hoffmann-La Roche Ltd. - Shionogi & Co., Ltd. - Amgen Inc. - Eli Lilly and Company - GlaxoSmithKline plc - Celltrion, Inc. - Novartis AG - Eisai Co., Ltd. - ImmunoGen, Inc. - Santaris Pharma A/S - CEL-SCI Corporation - OXiGENE, Inc. - Takara Bio Inc. - Panacea Biotec Limited - PCI Biotech AS - Nanobiotix - Acceleron Pharma, Inc. - Virttu Biologics Limited - Ascenta Therapeutics, Inc. - Onconova Therapeutics, Inc. - Genexine, Inc. - Viventia Biotechnologies Inc. - Oncovir, Inc. - Gliknik, Inc. - Karyopharm Therapeutics, Inc. - Agonox - Tolero Pharmaceuticals, Inc. - AlphaMab Co., Ltd For more information visit http://www.researchandmarkets.com/research/wm...d_and_neck
CVM: 0.62 (+0.03), IMGN: 5.90 (+0.13), AMGN: 160.67 (+3.15), LLY: 70.16 (+0.42), ONTX: 3.82 (+0.06), BMY: 59.15 (-0.01), GSK: 42.85 (+0.11), OXGN: 1.59 (unch), XLRN: 38.80 (+0.80), KPTI: 37.78 (+1.28), NVS: 93.91 (+0.66)

OXiGENE Announces Presentation of Phase 2 Data Confirming That Addition of Fosbretabulin to Bevacizumab Significantly Increases Progression-Free Survival in Recurrent Ovarian Cancer
GlobeNewswire - Mon Nov 10, 2:00AM CST
- Subgroup Analysis of GOG 186I Study Shows Benefit in Difficult-to-Treat Platinum-Resistant Patients -
OXGN: 1.59 (unch)

OXiGENE Down 5.8%, Shares Slide into the Red (OXGN)
Comtex SmarTrend(R) - Thu Nov 06, 10:09AM CST
OXiGENE (NASDAQ:OXGN) is one of today's worst performing low-priced stocks, down 5.8% to $2.27 on 1.3x average daily volume. Thus far today, OXiGENE has traded 783,000 shares, vs. average volume of 600,000 shares per day. The stock has underperformed the Dow (-5.8% to the Dow's 0.5%) and underperformed the S&P 500 (-5.8% to the S&P's 0.3%) during today's trading.
OXGN: 1.59 (unch)

Lower Your Expectations For OXiGENE's Presentation At The November 8 International Gynecologic Cancer Society Meeting
Clinically Sound Investor - at Seeking Alpha - Thu Nov 06, 9:15AM CST

OXGN: 1.59 (unch)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

ASU's International Enrollment Lead Carries Real Weight

Updated Category News Views 108

Twenty thousand nine hundred twenty-six international students is not a campus footnote; it is a serious operating force moving through Arizona State University and the state around it. ASU has held the No. 1 spot among U.S. public universities hosting international students for six straight years, and the 2026 Open Doors report puts it No. 2 across public and private...

Continue Reading
Neurelis Founder Earns EY's 2026 Top Entrepreneur Honor

Updated Category News Views 95

Some business awards are wallpaper; this one carries real clinical weight. EY US named Craig Chambliss, CEO and co-founder of Neurelis, its Entrepreneur Of The Year 2026 National Overall Award winner. In a sector where plenty of companies talk grandly about changing lives and then vanish into the regulatory fog, the underlying story matters more than the trophy. Neurelis...

Continue Reading
Allooloo's 100M Calls Test Capital Markets AI Data

Updated Category News Views 138

Forty-one point nine thousand issuers is a lot of financial clutter to keep straight, and Allooloo says its machines are getting called on to do precisely that at industrial scale. The Vancouver-based company reported on November 20 that its capital-markets data products now receive 100 million AI-agent calls a month—roughly 3.4 million daily, or 39 per second. That is...

Continue Reading
Greenberg Traurig Adds Privacy Muscle in Denver Office

Updated Category News Views 147

Privacy work used to be the legal department's back-room plumbing; now it can jam an entire product launch. That is why Greenberg Traurig's decision to bring Amber Mednick in as of counsel in Denver deserves more attention than the usual law-firm hiring blurb. This is not a splashy deal, and nobody should pretend one lateral hire rewrites the competitive map. Still, it is...

Continue Reading
Epiroc Takes Live Remote Drilling to CES 2027 Stage

Updated Category News Views 48

A drill rig chewing through Virginia rock from a Las Vegas convention booth is either a serious industrial-tech moment or an expensive magic trick. At CES 2027, Epiroc intends to make the distinction painfully clear. From January 6 through 9, the Stockholm-based mining-equipment company and Luck Stone will connect Booth 7031 in the LVCC West Hall to a working quarry in...

Continue Reading
Lara Kirchner's Surgical Leadership Earns Recognition

Updated Category News Views 64

Surgical care gets judged in the quiet moments nobody puts on a plaque: a sterile instrument ready when it must be, a handoff done cleanly, a team that does not let a rushed schedule turn into a bad outcome. That is why Lara L. Kirchner's recognition as a Pinnacle Professional of the Year deserves a more serious look than the usual congratulatory confetti. Kirchner is...

Continue Reading
CVS Puts Youth Soccer Stories on Its Store Shelves

Updated Category News Views 76

Two kids with real community ties just got a megaphone most grown-ups never receive. CVS Pharmacy has named Caroline, 9, of Holmes Beach, Florida, and Zoe, 12, of Los Angeles, as the first grand-prize winners of its Home Team Heroes youth soccer contest. Each player’s selected nonprofit soccer organization will receive a $25,000 grant, while their stories will appear on...

Continue Reading
West Virginia SEO Timelines Demand Patience, Not Hype

Updated Category News Views 99

A fresh website with no search footprint is not a race car; it is a pickup stuck in mud, and Sean O'Kelly's view of local SEO in West Virginia puts that inconvenient fact right on the table. Most businesses can expect measurable improvement after three to six months of consistent work, according to the HelloNation article. That is not a glamorous answer, but it is the...

Continue Reading
Triller Lawsuit Puts Merger Disclosures Under a Harsh Light

Updated Category News Views 90

A $0.32 closing price has a way of stripping the paint off a corporate story. The proposed securities class action involving Triller Group, Inc. puts a hard spotlight on a familiar, ugly market sequence: a splashy merger, glowing talk around acquired assets, delayed financial filings, Nasdaq trouble, and then a collapse severe enough to leave shareholders wondering what...

Continue Reading
California Rideshare Data Exposes an Insurance Gap

Updated Category News Views 27

Three California counties carried an outsized share of rideshare traffic, and the insurance fine print is where this story gets uncomfortable. A review by Mendez & Sanchez says Los Angeles, San Francisco, and San Diego counties accounted for nearly two-thirds of statewide rideshare trips between September 2019 and August 2020. That is an old snapshot, sure, but it points...

Continue Reading

Top 5 Most Recently Viewed Articles

Director Declaration - Northern 2 VCT PLC

Updated Category News Views 143

Director Declaration - Northern 2 VCT PLC Northern 2 VCT PLC (“the Company”) has announced that Ranjan Ramparia, who currently serves as a non-executive director and audit Chair of the Company, will take on a new role as a non-executive director at Keystone Positive Change Investment Trust plc. Disclosure Compliance In line with the UK Listing Rules, there are no...

Continue Reading
Exploring WisdomTree's Diverse Fund Offerings and Prices

Updated Category News Views 119

Understanding WisdomTree's Daily Fund Prices WisdomTree Issuer plc, renowned for its innovative investment strategies, provides a range of ETF products that cater to various investment needs. The company focuses on not just traditional asset classes but also on megatrends shaping the future. Investors looking to stay updated on their financial assets can explore the daily...

Continue Reading
Atlantic American Corporation Sees Positive Growth in Q1 Results

Updated Category News Views 198

Atlantic American Corporation Achieves Strong Q1 Performance Atlantic American Corporation (NASDAQ: AAME) recently announced its financial results for the first quarter of the year, showcasing a significant turnaround in performance. The company reported a net income of $0.8 million, translating to $0.03 per diluted share. This marks a remarkable recovery from a net loss...

Continue Reading
CTT's Growth in Q3 2024: A Promising Outlook for Q4

Updated Category News Views 80

CTT's Impressive Q3 Performance CTT (CTT.LS) reported a stellar third quarter, showcasing significant revenue growth and a bright outlook for the fourth quarter. As discussed by CEO Joao Bento, the company achieved a remarkable 17.3% increase in revenue, accompanied by a 28.6% rise in EBIT when excluding Financial Services. This transition period highlights CTT's...

Continue Reading
Global Leaders Unite for Climate Justice Summit in NYC

Updated Category News Views 186

Global Leaders Come Together for Climate Justice Summit in NYC The Climate Justice Summit: People Deliver marks a significant kickoff for Climate Week in New York City. This vibrant event will gather a broad spectrum of climate justice advocates from around the world, who will collaborate and share their insights. A coalition of key organizations, including the HBCU Green...

Continue Reading